Developing Iron Nanochelating Agents: Preliminary Investigation of Effectiveness and Safety for Central Nervous System Applications
Authors:
- Eleonora FiciaràEFEleonora Ficiarà
- Chiara MolinarCMChiara Molinar
- Silvia GazzinSGSilvia Gazzin
- Sri JayantiSri Jayanti
- Monica ArgenzianoMonica Argenziano
- Lucia NasiLucia Nasi
- Francesca CasoliFCFrancesca Casoli
- Franca AlbertiniFranca Albertini
- Shoeb Anwar AnsariSAShoeb Anwar Ansari
- Andrea MarcantoniAMAndrea Marcantoni
- Giulia TomagraGiulia Tomagra
- Valentina CarabelliValentina Carabelli
Open Access
- 5 January 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (2) , 729
Abstract
Excessive iron levels are believed to contribute to the development of neurodegenerative disorders by promoting oxidative stress and harmful protein clustering. Novel chelation treatments that can effectively remove excess iron while minimizing negative effects on the nervous system are being explored. This study focuses on the creation and evaluation of innovative nanobubble (NB) formulations, shelled with various polymers such as glycol-chitosan (GC) and glycol-chitosan conjugated with deferoxamine (DFO), to enhance their ability to bind iron. Various methods were used to evaluate their physical and chemical properties, chelation capacity in diverse iron solutions and impact on reactive oxygen species (ROS). Notably, the GC-DFO NBs demonstrated the ability to decrease amyloid-β protein misfolding caused by iron. To assess potential toxicity, in vitro cytotoxicity testing was conducted using organotypic brain cultures from the substantia nigra, revealing no adverse effects at appropriate concentrations. Additionally, the impact of NBs on spontaneous electrical signaling in hippocampal neurons was examined. Our findings suggest a novel nanochelation approach utilizing DFO-conjugated NBs for the removal of excess iron in cerebral regions, potentially preventing neurotoxic effects.Keywords
Funding Information
- University of Turin (RILO) (S1921_EX-POST_21_01, P2022CRAXJ)
- PRIN MUR 2022 (S1921_EX-POST_21_01, P2022CRAXJ)
This publication has 41 references indexed in Scilit:
- Nano-antioxidants: An emerging strategy for intervention against neurodegenerative conditionsNeurochemistry International, 2015
- Bud extracts from Tilia tomentosa Moench inhibit hippocampal neuronal firing through GABAA and benzodiazepine receptors activationJournal of Ethnopharmacology, 2015
- Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directionsJournal of Blood Medicine, 2015
- Sirtuin inhibitor sirtinol is an intracellular iron chelatorChemical Communications, 2015
- Brain Iron Homeostasis: From Molecular Mechanisms To Clinical Significance and Therapeutic OpportunitiesAntioxidants & Redox Signaling, 2014
- Leptin Counteracts the Hypoxia-Induced Inhibition of Spontaneously Firing Hippocampal Neurons: A Microelectrode Array StudyPLOS ONE, 2012
- Age-related Iron Deposition in the Basal Ganglia: Quantitative Analysis in Healthy SubjectsRadiology, 2009
- Structure, depolymerization, and cytocompatibility evaluation of glycol chitosanJournal of Biomedical Materials Research Part A, 2007
- Interactions between iron(III) and sucrose, dextran, or starch in complexesCarbohydrate Polymers, 2005
- Redox-active iron mediates amyloid-β toxicityFree Radical Biology and Medicine, 2001